Where Tech Meets Bio

Where Tech Meets Bio

Home
Podcast
Archive
About
13 Foundation Models: Startups, Industry Updates and the Nobel Prize
From AlphaFold’s Nobel recognition to emerging platforms in drug discovery, genomics, and digital biology—tracking the expanding field of foundation…
 • 
BiopharmaTrend
Weekly Tech+Bio Highlights #33: The "Holy Grail" of Digital Biology
Utility of DNA Language Models, Digital Pathology Fundraisers, & Can AI Filter Out What Won’t Dissolve?
 • 
BiopharmaTrend
 and 
Roman Kasianov
3
12 Startups in the Digital Twin Healthcare Ecosystem: From Virtual Organs to Optimized Trials
How virtual replicas guide decisions in medicine, trials, and patient care.
 • 
BiopharmaTrend
Most Popular
View all
Ex-NASA Expert Unveils Everything You Need to Know About Brain-Computer Interfaces
 • Andrii Buvailo
The '4th Wave' of AI Drug Discovery is Here, According to This Report
 • Andrii Buvailo
11 Biopharma Trends to Watch in 2024
 • Andrii Buvailo
Where Are We Now With AI-driven Drug Discovery?🎄
 • Andrii Buvailo and BiopharmaTrend
2
First Week Highlights of 2024
'Google Maps' of Human Cells
 • BiopharmaTrend, Roman Kasianov, and Andrii Buvailo
Weekly Tech+Bio Highlights #32: Chemical Lab Run by Multi-Agent AI
Also: AI in Materials Science, Humanoid Lab Robots, Summarizing Findings From 22M Scientific Papers, and more...
 • 
BiopharmaTrend
 and 
Roman Kasianov
Next Generation Sequencing: New Tech and Companies to Watch
From the discovery of the double helix to the latest AI-driven innovations.
 • 
BiopharmaTrend
Weekly Tech+Bio Highlights #31: Synthetic Biological Intelligence, China’s Growing Role In BCI
Google's Multimodal Medical AI; This Pharma Giant Reportedly Uses Claude AI to Draft Clinical Docs, and more...
 • 
BiopharmaTrend
 and 
Roman Kasianov
How Clinical Trial Design Choices Impact Speed, Risk, and Regulatory Outcomes?
A guest study providing insights from 10,000+ oncology clinical programs
 • 
BiopharmaTrend
1
Weekly Tech+Bio Highlights #30: Roche’s Comeback to Sequencing
Also: AI and Pharmacovigilance, Advances in Aging Research, and more...
 • 
BiopharmaTrend
 and 
Roman Kasianov
Weekly Tech+Bio Highlights #29
Also: This Company Suggests Six Criteria for Assessing AI’s Role in Drug Discovery, Modernizing Clinical Trials, AI-Designed Enzymes, New Ultrafast…
 • 
BiopharmaTrend
 and 
Roman Kasianov
Weekly Tech+Bio Highlights #28
Also: On Combination Therapies in Oncology, Alzheimer’s Prevention Antibody Trial, and more...
 • 
BiopharmaTrend
 and 
Roman Kasianov
Weekly Tech+Bio Highlights #27
Also: From LinkedIn to Drug Discovery; RNA Biomarkers for Predicting Better Responders; Recursion Expands into Clinical Trials, and More...
 • 
BiopharmaTrend
 and 
Roman Kasianov
Weekly Tech+Bio Highlights #26
Also: Market Myopia; Framework to Fight Antimicrobial Resistance; AI-driven Spatial Proteomics
 • 
BiopharmaTrend
 and 
Roman Kasianov
Where Tech Meets Bio
Where Tech Meets Bio
What does the future hold for us in the “century of biotech“?
Recommendations
View all 6
Special Competitive Studies Project
Special Competitive Studies Project
SCSP
The Algorithmic Bridge
The Algorithmic Bridge
Alberto Romero
The Connected Ideas Project
The Connected Ideas Project
Alexander Titus
AI Supremacy
AI Supremacy
Michael Spencer
Noahpinion
Noahpinion
Noah Smith

Where Tech Meets Bio

AboutArchiveRecommendationsSitemap
© 2025 BiopharmaTrend (BPT Analytics Ltd)
Privacy ∙ Terms ∙ Collection notice
Start WritingGet the app
Substack is the home for great culture